2022
Readmission and adverse outcomes after percutaneous coronary intervention in patients with dementia
Park D, Hu J, Alexander K, Nanna M. Readmission and adverse outcomes after percutaneous coronary intervention in patients with dementia. Journal Of The American Geriatrics Society 2022, 71: 1034-1046. PMID: 36409823, PMCID: PMC10089937, DOI: 10.1111/jgs.18120.Peer-Reviewed Original ResearchConceptsPercutaneous coronary interventionInhospital adverse eventsKidney injuryAdverse eventsCoronary interventionAdverse outcomesHigher readmission riskMultivariable Cox modelingAcute kidney injuryThirty-day readmissionIschemic heart diseaseCox proportional hazardsLogistic regression modelingDiagnosis of dementiaInhospital mortalityNoncardiac proceduresIndex hospitalizationReadmission ratesCox modelingReadmission riskCardiac arrestHeart diseasePCI experienceHigher oddsReadmission
2021
Estimating the real-world performance of the PROMISE minimal-risk tool
Nanna MG, Wang TY, Chiswell K, Sun JL, Vemulapalli S, Hoffmann U, Patel MR, Udelson JE, Fordyce CB, Douglas PS. Estimating the real-world performance of the PROMISE minimal-risk tool. American Heart Journal 2021, 239: 100-109. PMID: 34077743, DOI: 10.1016/j.ahj.2021.05.016.Peer-Reviewed Original ResearchMeSH KeywordsAngina, StableComputed Tomography AngiographyCoronary AngiographyCoronary StenosisCoronary VesselsFemaleHeart Disease Risk FactorsHumansMaleMedical OveruseMiddle AgedMyocardial InfarctionMyocardial RevascularizationOutcome and Process Assessment, Health CarePrognosisRisk AssessmentUnited StatesConceptsObstructive coronary artery diseaseNon-low risk patientsLow-risk patientsCoronary artery diseaseStable chest painRisk patientsCardiac catheterizationArtery diseaseChest painMyocardial infarctionLower riskProspective Multicenter Imaging StudyStable chest pain patientsCardiovascular adverse outcomesMI-free survivalChest pain patientsObstructive coronary diseaseElective cardiac catheterizationLikelihood of freedomLogistic regression modelingOutcomes of interestPositive predictive valueAlternative cut pointsIndex angiographyIndex catheterization
2020
Prevalence, treatment, and control of severe hyperlipidemia
Gold ME, Nanna MG, Doerfler SM, Schibler T, Wojdyla D, Peterson ED, Navar AM. Prevalence, treatment, and control of severe hyperlipidemia. American Journal Of Preventive Cardiology 2020, 3: 100079. PMID: 34327462, PMCID: PMC8315339, DOI: 10.1016/j.ajpc.2020.100079.Peer-Reviewed Original ResearchLDL-C controlHigh-intensity statinsLDL-C levelsLow-density lipoprotein cholesterol controlLDL-C treatment goalsPrior atherosclerotic cardiovascular diseaseMultivariable logistic regression modelingHealth systemDuke University Health SystemAtherosclerotic cardiovascular diseaseLDL-C measurementAfrican American raceCross-sectional prevalenceUniversity Health SystemUnited States adultsGreater reductionLogistic regression modelingContemporary clinical practiceIntensity statinsHigh LDLAppropriate therapyCholesterol controlSevere hyperlipidemiaFemale sexCardiovascular disease